

How the GLP-1 Boom Turned Eli Lilly Into Biopharma’s Biggest Buyer
Few drugs have transformed a pharmaceutical company as quickly as GLP-1s have transformed Eli Lilly. In the second quarter of 2026, Eli Lilly reported $23 billion in revenue, which was a whopping 48% increase from the year before. How they did it? Tirzepatide. Tirzepatide is an injectable medication sold under two brand names. Mounjaro for diabetes and Zepbound for obesity. Mounjaro generated $9.9 billion in quarterly sales, while Zepbound added another $4.9 billion. Together
Evan Wang
6 hours ago2 min read


The AI War Is Moving From Intelligence to Economics
Within 48 hours, two of the most dominant artificial intelligence companies released their brand-new models. Anthropic pushed out Claude Fable 5.1 on September 1, 2026, followed by OpenAI’s release of GPT-6 Astra on September 3, 2026. The two models are the most capable of their predecessors, and both currently sit atop the AI benchmark rankings. However, the more important story may be what their releases mean for where the AI race is heading next. For years, competition rev
Evan Wang
8 hours ago2 min read


Why Big Pharma Is Spending Billions on Drugs It Didn’t Invent
Would you take a chance on a drug that is unfinished but could generate billions in future revenue? For the world’s largest pharmaceutical companies, the answer is yes. Rather than discovering a drug from scratch, Big Pharma has increasingly begun licensing and acquiring drugs from smaller biotech companies or outright buying the companies as a whole. However, they aren’t investing in a finished result, but in a set of rights, patents, and pipelines. While you may think they
Evan Wang
2 days ago2 min read


The Race for America's Brightest Minds
The United States is renowned for attracting the world’s smartest scientists, researchers, and entrepreneurs. High salaries, leading universities, and enormous amounts of research funding make America one of the best places in the world to build a career. Recently, that trend seems to be reversing. One Nature survey found that 75% of researchers in the U.S. are considering leaving the country. Applications from American scientists seeking jobs in Canada increased by 41%, and
Daniel Reznik
Aug 112 min read


How Peter Thiel Built His Fortune
Peter Thiel is one of Silicon Valley’s wealthiest and most influential investors; unlike Elon Musk and Mark Zuckerberg, though, most of his fortune doesn’t come from one single company. Thiel has spent decades building a network of investments across various industries like technology, finance, defense, and politics. His rise began with PayPal. After initially investing $100,000 into the company that became PayPal, he received an even bigger payout after eBay acquired it in 2
Daniel Reznik
Aug 81 min read


Can GTA VI Save Modern Gaming?
The video game industry should be having its best years ever. More people are playing games, spending more time playing, and buying more in-game content. The video game industry currently generates between $200 and $350 billion in annual revenue, making it one of the largest forms of entertainment in the world. However, many of the companies behind these games are struggling internally. One of the major problems is that gamers are spending more time playing fewer games. In 20
Daniel Reznik
Aug 41 min read
